HRS-9563 Injection for Mild Hypertension

This study is exploring a new treatment option for individuals with mild hypertension, a condition where blood pressure is higher than normal but not severely high. The research focuses on a medication called HRS-9563 and aims to understand if it is safe and well-tolerated when given as a single injection under the skin. The study targets those with mild hypertension, hoping to find a potentially effective treatment that could help manage blood pressure in a new way. Participants in the study will receive a single subcutaneous, or under the skin, injection of HRS-9563. The study is set up in a way that neither the participants nor the researchers know who receives the active medication and who receives a placebo, ensuring unbiased results. Researchers will monitor participants closely to evaluate how their bodies react to the injection, focusing on any side effects and how well the medication is tolerated. This careful monitoring is crucial to ensure participant safety and to gather accurate data on the medication's effects.